Certified Gastroenterology Registered Nurse Practice Exam 2026 – Comprehensive All-in-One Guide for Exam Success

Hypophosphatemia, which refers to low levels of phosphate in the blood, is frequently linked to the increased use of aluminum-containing antacids. These antacids can bind phosphate in the gastrointestinal tract, leading to decreased absorption and contributing to lower serum phosphate levels. As aluminum compounds neutralize gastric acid, they can form insoluble complexes with phosphate, resulting in reduced phosphate availability for absorption into the bloodstream. This mechanism is particularly relevant in patients who may be using these antacids chronically or in high doses, which makes it a significant consideration in the management of hypophosphatemia.

In contrast, other options do not have the same established connection with hypophosphatemia. Increased calcium intake does not directly impact phosphate levels in the same way aluminum-containing antacids do. Excessive protein consumption typically serves to increase phosphate levels, as protein-rich foods contain significant amounts of phosphorus. Similarly, a high-fat diet does not inherently lead to low phosphate levels and is more associated with other metabolic issues. Therefore, among the choices, the increase use of aluminum-containing antacids is the most relevant factor contributing to hypophosphatemia.